| B |
|
Bb448 Lys/Lys variant alters coronary risk by an effect on fibrin structure/function due to conformational changes in fibrinogen
|
| Lim B. C. B., Ariens R. A. S., Weisel J. W., Grant P. J. |
| |
|
Basal Fibrinogen and FVIII:C Concentrations are not Associated with Polymorphisms in the Interleukin-1 Gene Cluster
|
| Marsden L., Timms J. M., Cox A., Sampson B. M., Woolley A. M., Makris M., Daly M. |
| |
|
Basal levels of phosphatidylserine exposure on the cell-surface of T-lymphoblastoid and monocytoid cells: relationship to Prothrombin and FX activation, and Tissue Factor activity
|
| Pickering W., Gray E., Goodall A. H., Appleby J. A., Ran S., Thorpe P. E., Barrowcliff T. W. |
| |
|
Baseline characteristics, risk factor profile and outcomes of patients treated for venous thromboembolic disease with low molecular weight heparin (enoxaparin) – the Venous Thromboembolism Registry (VERITY)
|
| O'Shaughnessy D., Rose P., Cummins D., Scriven N., Kinsman R., Walton P., Amlot N. |
| |
|
Baseline thrombophilic markers do not predict deep venous thrombosis in medical–surgical ICU patients
|
| Crowther M., Cook D. J. C., Meade M., Griffith L., Rabbat C., Guyatt G., Johnston M., Mcdonald E., Landry F. |
| |
|
Behaviour of the protein C (PC)/protein S (PS) ratio in patients with thrombosis
|
| Blanco A., Gennari L. C., Nadal M. V., Domínguez M. P., Meschengieser S., Lazzari M. A. |
| |
|
Below-knee elastic compression stockings for prevention of the post–thrombotic syndrome in patients with proximal-vein thrombosis: a prospective controlled randomized study
|
| Prandoni P., Frulla M., Marchiori A., Bernardi E., Tormene D., Mosena L., Sartor D., Lensing A. W. A., Prins M. H., Girolami A. |
| |
|
Benefit and risk of heparin addition in maintaining peripheral venous catheters in neonates – a prospective, double-blind, placebo-controlled trial
|
| Klenner A., Fusch C., Rakow A., Beyersdorff E., Wander K., Lietz T., Eichler P., Greinacher A. |
| |
|
Best practices in Orthopedic surgery
|
| Eriksson B. |
| |
|
Beta-2 integrin adhesion triggered by E-selectin in human PMN: role of SRC kinases and of an unidentified receptor
|
| Totani L., Piccoli A., Manarini S., Martelli N., Pecce R., Cerletti C., Piccardoni P., Evangelista V. |
| |
|
Bilateral deep-vein thrombosis and cancer: prospective study of 103 patients
|
| Bura A., Cailleux N., Bienvenu B., Léger PH., Bissery A., Boccalon H., Fiessinger J.-N., Levesque H., Emmerich J. |
| |
|
Binding at two distinct exosites is required for activation of prothrombin by prothrombinase
|
| Lockett J. M., Sheehan J. P., Mast A. E. |
| |
|
Binding of b2-glycoprotein I and dimeric b2-glycoprotein I to members of the low-density lipoprotein receptor superfamily: implications for the anti-phospholipid syndrome
|
| Lutters B. C. H., Van Lummel M., Van Scherpenzeel M., Derksen R. H. W. M., Lenting P. J., De Groot P. G. |
| |
|
Binding of covalent antithrombin–heparin complex to endothelial cells
|
| Paredes N., Berry L. R., Thong B., Chindemi P., Chan A. K. C. |
| |
|
Binding of heparin to alkaline earth and transition metals
|
| Parmar N., Paredes N., Berry L. R., Kim E., Chan A. K. C. |
| |
|
Binding of minute amounts of thrombin to GPIbalpha accelerates early platelet reactions, but not the platelet procoagulant response
|
| Ulrichts H., Keuren J., Vanhoorelbeke K., Wielders S., Feige M., Heemskerk J., Lindhout J., Deckmyn H. |
| |
|
Binding to a negatively charged surface alters the conformation of factor XIa
|
| Sinha D., Badellino K., Marcinkiewicz M., Walsh P. N. |
| |
|
Biochemical fibrinogen modification and atherogenesis
|
| Partyka L., Aghajanian A. A., Polus A., Weigel G., Sinzinger H., Dembinska-Kiec A. |
| |
|
Biochemical, immunologic and computer-modeling evidence localizing the mAb 7E3 Epitope on aIIbb3
|
| Artoni A., Li J. H., Mitchell W. B., Ruan J., Coller B. S., French D. L. |
| |
|
Biological and clinical DDAVP response in children with von Willebrand disease (VWD)
|
| Bonduel M., Frontroth J. P., Hepner M., Sciuccati G., Pieroni G., Felíu Torres A. |
| |
|
Biological and pathological roles of thrombomodulin
|
| Weiler H., Isermann B. H. |
| |
|
Biological and pharmacokinetic activity of the new recombinant thrombolytic and anthithrombotic agent RGD SAK-K2-HIR
|
| Szemraj J., Chabielska E., Rozponczyk E., Walkowiak B., Kawecka I., Janizewska G., Buczko W., Bartowiak J. |
| |
|
Biological effects of sulodexide on hemostatic risk factors of thrombogenesis
|
| Lasierra J., Coronel P., Cuevas B., Benedicto D. |
| |
|
Biosynthesis and assembly of FVIII–vWF complex
|
| Montgomery R. R. |
| |
|
Biosynthesis and secretion of coagulation factor VIII
|
| Kaufman R. |
| |
|
Biphasic human platelet response to cGMP mediated via distinct signaling pathways: a predominant role for cAMP-dependent protein kinase in the cGMP-induced platelet inhibition and phosphorylation of vasodilator-stimulated phosphoprotein
|
| Li Z., Ajdic J., Eigenthaler M., Du X. |
| |
|
Biphasic PTT waveform and adverse events in nonintensive care unit patients
|
| Smith E. Y., Charles L. A., Van Cott E. M. |
| |
|
Birth of the platelet
|
| Hartwig J., Italiano Jr J. |
| |
|
Bivalirudin, a direct thrombin inhibitor, in the treatment of heparin-induced thrombocytopenia
|
| Francis J., Drexler A., Gwyn G., Moroose R. |
| |
|
Bleeding due to platelet disorders - and treatment: Experiences with rFVlla in thrombocytopenic patients
|
| Goodnough G. |
| |
|
Bleeding due to platelet disorders - and treatment: Mechanism of action of rFVlla in quantitive and qualitive disorders of platelent function
|
| Escolar G. |
| |
|
Bleeding due to platelet disorders - and treatment: Review of current and future anticoagulants and their potential reversal by rFVlla
|
| Kessler C. |
| |
|
Bleeding in patients with factor XII deficiency may relate to concomitant platelet function disorders if von Willebrand's disease is excluded
|
| Mainwaring J., Needham J., Mensah P., Lewis H., Knight S., Roy A. |
| |
|
Bleeding phenotype and decreased viability in rap1b knockout mice
|
| Wodnicka M. B., Fischer T. H., Cullen J., Hilliard E., Shattil S., Brass L. F., White G. C. |
| |
|
Bleeding symptoms, von Willebrand factor (vWF) and von Willebrand's disease in Icelandic teenagers. The Bleeding Assessment in Teenagers (BAT) Study
|
| Onundarson P. T., Gudmundsdottier A. |
| |
|
Blockade of GPIIb/IIIa by abciximab, eptifibatide and tirofiban at high shear results in a differential inhibition of platelet aggregation, platelet microparticle formation and phosphatidylserine exposure
|
| Pontiggia L., Steiner B., Beer J. H. |
| |
|
Blood coagulation during mural throbogenesis under whole blood flow conditions with high shear rates
|
| Matsui H., Sugimoto M., Mizuno T., Hamada M., Miyata S., Matsuda M., Yoshioka A. |
| |
|
Blood glutathione detects pro-oxidant patterns in mild hyperhomocysteinemia associated with atherothrombotic vascular events
|
| Parodi O., Baudo F., Devoto E., De Maria R., De Chiara B., Campolo J., Caruso R., Brunelli C., Accinni R. |
| |
|
Blood transfusion is associated with an enhanced pro angiogenic state
|
| Patel H., Nasir F., Nash G., Scully M. F., Kakkar A. K. |
| |
|
Blood-borne tissue factor aggravates the outcome of endotoxemia
|
| Schoenmakers S. H. H. F., Groot A. P., Florguin S., Reitsma P. H., Spek C. A. |
| |
|
Both shear and temperature can profoundly alter antithrombotic drug efficacy: demonstration with the P2Y12 ADP receptor antagonist, ARC-69931MX
|
| Frojmovic M., Zolotarova E. |
| |
|
Bovine heparin results in higher generation of functional anti-heparin-PF4 antibodies than porcine heparin following coronary artery bypass surgery
|
| Ahmad S., Drexler A., Reyes E., Meyer T. V., Palmer I. I. I., Moroose G. J. R., Francis J. L. |
| |
|
Brain natriuretic peptide (BNP) as a predictor of adverse outcome in patients with pulmonary embolism
|
| Ten Wolde M., Tulevski I. I., Mulder J. W. M., Söhne M., Boomsma F., Douketis J. D., Mulder B. J. M., Büller H. R. |
| |
|
Bridging therapy for mechanical heart valves: a model comparing unfractionated and low molecular weight heparin
|
| Garcia D., Rich J. S., Libby E. |
| |
|
Burden of von Willebrand disease in India
|
| Mohanty D., Trasi S., Shetty S., Pathare A., Ghosh K. |
| |
